GSK
817 hedge funds and large institutions have $11.9B invested in GSK in 2020 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 267 increasing their positions, 338 reducing their positions, and 132 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
12% less capital invested
Capital invested by funds: $13.5B → $11.9B (-$1.67B)
21% less repeat investments, than reductions
Existing positions increased: 267 | Existing positions reduced: 338
48% less first-time investments, than exits
New positions opened: 69 | Existing positions closed: 132
Holders
817
Holding in Top 10
16
Calls
$113M
Puts
$64.4M
Top Buyers
| 1 | +$336M | |
| 2 | +$286M | |
| 3 | +$153M | |
| 4 |
Rockefeller Capital Management
New York
|
+$144M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$114M |
Top Sellers
| 1 | -$89.1M | |
| 2 | -$66.2M | |
| 3 | -$49.6M | |
| 4 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
-$40.2M |
| 5 |
JPMorgan Chase & Co
New York
|
-$37.2M |